News: MAP Microba Life Sciences To Acquire Invivo Clinical

Oct 19 (Reuters) - Microba Life Sciences Ltd (MAP) :

• MICROBA TO ACQUIRE UK MICROBIOME LEADER INVIVO CLINICAL
• ACQUISITION EXPANDS MICROBA'S SCALE AND INTERNATIONAL PRESENCE WITH FY23 REVENUES OF A$14.3M ON A PRO-FORMA BASIS
• WILL BE ACQUIRED FOR A PURCHASE PRICE OF APPROXIMATELY A$12.5 MILLION, PLUS UP TO A$8.7 MILLION IN EARN-OUT CONSIDERATION
• SIGNED A SHARE PURCHASE AGREEMENT FOR ACQUISITION OF 100% OF INVIVO CLINICAL LIMITED
• EXPECTED ABOUT 87 MILLION SHARES WILL BE ISSUED UNDER ENTITLEMENT OFFER
• POST ENTITLEMENT OFFER, MICROBA’S PRO FORMA NET CASH AT 30 SEPT EXPECTED TO BE A$28.3 MILLION